Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 10:31 PM UTC
| NCT Number | NCT06787612 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE2 |
| Target Enrollment | 297 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT06787612 is currently recruiting participants. This phase2 study for ovarian cancer is actively seeking new participants at 21 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06787612 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06787612 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.